Technical Analysis for MDP - Medexus Pharmaceuticals Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Flat | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Wide Range Bar | Range Expansion | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Boomer Sell Setup | Bearish Swing Setup | 15.02% | |
MACD Bullish Signal Line Cross | Bullish | 15.02% | |
NR7 | Range Contraction | 15.02% | |
NR7-2 | Range Contraction | 15.02% | |
Narrow Range Bar | Range Contraction | 15.02% | |
Inside Day | Range Contraction | 15.02% |
Free Daily (Stock) Chart Reading
- Earnings date: 2024-09-20
Medexus Pharmaceuticals Inc. Description
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.
Classification
Keywords: Health Healthcare Infrastructure Pipe Pharma Pipeline Pharmaceutical Integrated Disease Drugs Pharmaceuticals Diseases Arthritis Medication Immunosuppressants Rheumatoid Arthritis Cnx Nifty Pharmaceutical Business Sector Pharmaceutical Industry In China
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.16 |
52 Week Low | 1.44 |
Average Volume | 31,091 |
200-Day Moving Average | 2.039 |
50-Day Moving Average | 2.462 |
20-Day Moving Average | 2.243 |
10-Day Moving Average | 2.126 |
Average True Range | 0.150 |
RSI (14) | 57.26 |
ADX | 41.27 |
+DI | 26.759 |
-DI | 28.394 |
Chandelier Exit (Long, 3 ATRs) | 2.169 |
Chandelier Exit (Short, 3 ATRs) | 2.161 |
Upper Bollinger Bands | 2.614 |
Lower Bollinger Band | 1.872 |
Percent B (%b) | 0.78 |
BandWidth | 33.090 |
MACD Line | -0.078 |
MACD Signal Line | -0.105 |
MACD Histogram | 0.0272 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.005 | ||||
Resistance 3 (R3) | 2.943 | 2.697 | 2.913 | ||
Resistance 2 (R2) | 2.697 | 2.555 | 2.728 | 2.882 | |
Resistance 1 (R1) | 2.573 | 2.468 | 2.635 | 2.635 | 2.851 |
Pivot Point | 2.327 | 2.327 | 2.358 | 2.358 | 2.327 |
Support 1 (S1) | 2.203 | 2.185 | 2.265 | 2.265 | 2.049 |
Support 2 (S2) | 1.957 | 2.098 | 1.988 | 2.018 | |
Support 3 (S3) | 1.833 | 1.957 | 1.988 | ||
Support 4 (S4) | 1.895 |